Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Weiss

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Life Sciences|November 22, 2019
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I<sub>Kado</sub>Victor P Long, Ingrid M Bonilla, Stephen Baine, et al.
Circulation. Arrhythmia and Electrophysiology|May 21, 2013
Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillationIsmail Hamam, Emile G Daoud, Jianying Zhang, et al.
Journal of Cardiovascular Electrophysiology|July 3, 2018
Feasibility of concomitant vacuum-assisted removal of lead-related vegetations and cardiac implantable electronic device extractionHemant Godara, Kelly Qi Jia, Ralph S Augostini, et al.
JACC. Clinical Electrophysiology|January 31, 2021
Resource Use and Economic Implications of Remote Monitoring With Subcutaneous Cardiac Rhythm MonitorsMuhammad R Afzal, Anish Nadkarni, Laurie Niemet, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Indian Pacing and Electrophysiology Journal|December 12, 2017
Initiation and outcomes with Class Ic antiarrhythmic drug therapyXu Gao, Avirup Guha, Benjamin Buck, et al.
Heart Rhythm|May 16, 2017
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative resultsMichael R Gold, Johan D Aasbo, Mikhael F El-Chami, et al.
Journal of Cardiovascular Electrophysiology|November 22, 2013
Ibandronate and ventricular arrhythmia riskIngrid M Bonilla, Pedro Vargas-Pinto, Yoshinori Nishijima, et al.
Circulation|May 20, 2014
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mappingQing Lou, Brian J Hansen, Olga Fedorenko, et al.
Heart Rhythm|November 18, 2017
Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillatorMuhammad R Afzal, Divyesh Mehta, Christopher Evenson, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Life Sciences|November 22, 2019
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I<sub>Kado</sub>Victor P Long, Ingrid M Bonilla, Stephen Baine, et al.
Circulation. Arrhythmia and Electrophysiology|May 21, 2013
Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillationIsmail Hamam, Emile G Daoud, Jianying Zhang, et al.
Journal of Cardiovascular Electrophysiology|July 3, 2018
Feasibility of concomitant vacuum-assisted removal of lead-related vegetations and cardiac implantable electronic device extractionHemant Godara, Kelly Qi Jia, Ralph S Augostini, et al.
JACC. Clinical Electrophysiology|January 31, 2021
Resource Use and Economic Implications of Remote Monitoring With Subcutaneous Cardiac Rhythm MonitorsMuhammad R Afzal, Anish Nadkarni, Laurie Niemet, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Indian Pacing and Electrophysiology Journal|December 12, 2017
Initiation and outcomes with Class Ic antiarrhythmic drug therapyXu Gao, Avirup Guha, Benjamin Buck, et al.
Heart Rhythm|May 16, 2017
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative resultsMichael R Gold, Johan D Aasbo, Mikhael F El-Chami, et al.
Journal of Cardiovascular Electrophysiology|November 22, 2013
Ibandronate and ventricular arrhythmia riskIngrid M Bonilla, Pedro Vargas-Pinto, Yoshinori Nishijima, et al.
Circulation|May 20, 2014
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mappingQing Lou, Brian J Hansen, Olga Fedorenko, et al.
Heart Rhythm|November 18, 2017
Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillatorMuhammad R Afzal, Divyesh Mehta, Christopher Evenson, et al.
Pageof 11